Atlas FDA

VIDAS Testosterone, Ref 30418

FDA device recall Z-2339-2017 · posted 2017-06-29 · Terminated

Recall details

Recalling firm
bioMerieux, Inc.
Reason for recall
Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.
Action taken
An Urgent Product Safety Notice was sent on 5/15/2017 to consignees. The Notice requested that they discontinue use and discard any remaining inventory of the product, and to identify any possible falsely over estimated results and determine appropriate actions if relevant. The Notice also included a response form to be returned to Biomerieux.
Root cause
Under Investigation by firm
Status
Terminated
Product code
CDZ
Quantity affected
742
Distribution
AR, CA, CO, GA, IL, IA, MI, MN, MT, NY, OK, TN, TX, WY, Columbia, Costa Rica, El Salvador, France, Hong Kong, Jordan, Nicaragua, Russian Fed., Sri Lanka, Sweden, Ukraine
Date initiated
2017-05-15
Date posted
2017-06-29
Date terminated
2020-06-11
Location
Durham, NC

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
VIDAS TESTOSTERONE (TES), MODEL 30 418 (K021326)bioMerieux, Inc.2002-07-18